Pharmacokinetic (PK) models describe the relationship between the administe
red dose and the concentration of drug (and/or metabolite) in the blood as
a function of time. Pharmacodynamic (PD) models describe the relationship b
etween the concentration in the blood (or the dose) and the biologic respon
se. Population PK/PD studies aim to determine the sources of variability in
the observed concentrations/responses across groups of individuals. In thi
s article, we consider the joint modeling of PK/PD data. The natural approa
ch is to specify a joint model in which the concentration and response data
are simultaneously modeled. Unfortunately, this approach may not Lie optim
al if, due to sparsity of concentration data, all overly simple PK model is
specified. As all alternative, we propose all errors-in-variables approach
in which the observed-concentration data are assumed to be measured with e
rror without reference to a specific PK model. We give all example of all a
nalysis of PK/PD data obtained following administration of all anticoagulan
t drug. The study was originally carried out in order to make dosage recomm
endations. The prior for the distribution of the true concentrations, which
may incorporate all individual's covariate information, is derived as a pr
edictive distribution from all earlier study. The errors-in-variables appro
ach is compared with the joint modeling approach and more naive methods in
which the observed concentrations, or the separately modeled concentrations
, are substituted into the response model. Throughout, a Bayesian approach
is taken with implementation via Markov chain Monte Carlo methods.